Anthony Costello

Chief Executive Officer

Anthony Costello is CEO of Medidata, a Dassault Systèmes company. For over 25 years, Anthony has worked to redefine how clinical trials are conducted, transforming the patient, site, and sponsor experience while accelerating the delivery of life-changing treatments. Through his founding and nurturing of companies from start-up to commercial success, he has played a critical role in the development of revolutionary technologies—including decentralized trials—pioneering the use of data solutions and advanced analytics to empower patients via experience-led platforms. 

Throughout his career, Anthony has been the driving force behind the creation of innovative solutions designed to address the life science industry’s most pressing challenges. His accomplishments across the Medidata organization span key strategic planning, critical sales initiatives, and serving as the customer and market-facing representative for the Medidata story. In his previous role as CEO of Medidata Patient Cloud, Anthony led the development of patient-facing activities and solutions. Under his leadership, Medidata announced several groundbreaking new products and capabilities including the myMedidata patient portal, patient registries, telehealth and virtual visits, Sensor Cloud (Medidata’s advanced system for wearable sensors and digital biomarker discovery), and Health Record Connect, Medidata’s newest technology for connecting patient health records and clinical trial data. Anthony was also a champion for the award-winning Medidata Diversity Program, the industry’s most comprehensive solution to diverse studies. These industry-leading products support better study design, reduce patient burden, improve diversity, and create connected experiences, demonstrating his relentless dedication to transforming the broader life sciences ecosystem.

Anthony’s impactful contributions resulted in Medidata's recognition as a market leader in Everest Group's "Decentralized Clinical Trial Platforms PEAK Matrix® Assessment 2023," with an exclusive "Star Performer" designation for two consecutive years. He is the former Chairman of the Board for the Society for Clinical Data Management (SCDM), co-founder of Nextrials (acquired by PRA Health Sciences) and Mytrus (acquired by Medidata), and named one of PharmaVoice’s Top 100 Most Inspiring People in Clinical Research. He also serves as a board observer for Circuit Clinical, and is the executive sponsor of Medidata’s award-winning Social Innovation Lab, a skills-based volunteering program that pairs employees with non-profit partners.